MarketWatch
US · 3 hrs ago
✦ 78◉ Centre
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Zealand Pharma's stock price fell significantly after the company reported that approximately 20% of trial participants discontinued its weight-loss medication due to gastrointestinal side effects.
Zealand Pharma loses a fifth of its value as many users gave up taking weight-loss drug during trial
The drugmaker’s shares tumbled in Copenhagen after saying a fifth of users discontinued its weight-loss drug because of gastrointestinal issues.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!